Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify asthma-COPD overlap

T. Shirai (Shizuoka, Japan), K. Hirai (Shizuoka, Japan), Y. Gon (Tokyo, Japan), S. Maruoka (Tokyo, Japan), K. Mizumura (Tokyo, Japan), M. Hikichi (Tokyo, Japan), K. Itoh (Shizuoka, Japan), S. Hashimoto (Tokyo, Japan)

Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Session: Severe asthma phenotypes and outcomes
Session type: Oral Presentation
Number: 5040
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Shirai (Shizuoka, Japan), K. Hirai (Shizuoka, Japan), Y. Gon (Tokyo, Japan), S. Maruoka (Tokyo, Japan), K. Mizumura (Tokyo, Japan), M. Hikichi (Tokyo, Japan), K. Itoh (Shizuoka, Japan), S. Hashimoto (Tokyo, Japan). Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify asthma-COPD overlap. 5040

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: